Novel MOF P/ZnO Nanocomposite Shows Promise for Targeted Cancer Therapy
A new metal-organic framework (MOF P) integrated with ZnO nanoparticles shows effective cancer cell apoptosis and reduced viability.
Therapeutic Area
Therapeutic area intelligence for Nanomedicine with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.